SEATTLE and VANCOUVER, BC, Oct. 29,
2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq:
ACHV), a clinical-stage pharmaceutical company committed to
the global development and commercialization
of cytisinicline for smoking cessation and nicotine
addiction, today announced that it will report its third
quarter 2020 financial results and provide an update on the
cytisinicline development program on Thursday, November 12,
2020 at 4:30PM ET.
To access the webcast, log on to the Investor Relations page of
the Achieve website at
http://ir.achievelifesciences.com/events-and-webcasts.
Alternatively, you may access the live conference call by dialing
(877) 472-9809 (U.S. & Canada)
or (629) 228-0791 (International) and
referencing conference ID 8047128. A webcast
replay will be available approximately two hours after the call and
will be archived on the website for 90 days.
Achieve Contact
Jason Wong
jwong@bplifescience.com
(415) 375-3340 ext. 4
View original content to download
multimedia:http://www.prnewswire.com/news-releases/achieve-life-sciences-to-announce-third-quarter-2020-financial-results-and-host-conference-call-and-webcast-on-november-12-2020-301162254.html
SOURCE Achieve Life Sciences, Inc.